Zeotap CDP Pricing Overview

No. According to G2 data, Zeotap CDP does not offer a free plan or free trial. Users need to purchase a paid plan to access the product. Visit the seller's official pricing page for current pricing details and plan options.

Zeotap CDP's pricing is best suited for enterprise and mid-market organizations with mature data strategies and sufficient budget to justify a long-term commitment. G2 reviewers from retail, telecommunications, pharmaceuticals, leisure and travel, and marketing and advertising industries dominate the review base, with enterprise-segment users most frequently citing use cases like 1st-party data unification, offline-to-online onboarding, cookieless identity resolution, and programmatic audience activation. G2 reviews of Zeotap CDP also show mid-market firms in banking, automotive, and education deriving strong value. Smaller businesses appear in reviews but occasionally flag pricing as a stretch, making Zeotap CDP's pricing most defensible for organizations running complex, multi-channel data activation programs at scale.

Zeotap CDP offers no free tier or publicly listed pricing tiers, and G2 data on Zeotap CDP confirms the pricing model is based entirely on custom enterprise quotes. One G2 reviewer from banking noted being unable to obtain a free trial for an onboarding use case, and an online media reviewer flagged that Zeotap CDP's sales team required at least a one-year commitment without offering a trial period. Zeotap CDP's paid plans therefore represent the sole entry point, with access to the full stack including CDP, identity resolution, data clean rooms, and audience activation determined by negotiated commercial terms rather than tiered self-serve options.

G2 reviewers broadly rate Zeotap CDP highly, with most reviews at 4.0 to 5.0 stars, suggesting strong satisfaction relative to cost. However, pricing concerns surface repeatedly: multiple G2 reviewers describe Zeotap CDP's pricing as high, one noting the annual license fee is expensive for smaller agency clients, another flagging that 3rd-party data targeting alone can be pricier than competitors. A pharma enterprise reviewer explicitly warned that companies must fully commit to extract ROI. That said, reviewers consistently cite superior match rates over previous CDPs like Neustar, dedicated CSM support, and robust identity resolution as justifications for the premium, framing Zeotap CDP's pricing as a worthwhile investment for data-mature organizations.